US Equity · NASDAQ · Earnings Dossier

LFCR earnings intelligence

Lifecore Biomedical Inc.

Healthcare · Drug Manufacturers - Specialty & Generic · USD reporting basis

Current earnings profile Delivery under pressure

Estimate misses and negative next-close reactions have appeared together often enough to warrant caution.

Evidence87/100 · Deep

Next scheduled catalyst

No forward date is currently stored

The historical dossier remains available while the next calendar date is unconfirmed.

0event risk

Inactive

Countdown-calendar proximity
EPS estimate-provider consensus
Estimate growth-versus comparable year-ago actual
Historical movement14.2%average absolute next weekly close

Three-year earnings transmission

Delivered earnings power versus market price

Three-year relationship unavailable

Earnings power must be positive at the start of the three-year window.

Beat rate33.3%4 beats in 12 measured quarters
Average surprise-11.5%median -0.2%
Delivery streak11 consecutive in-line reports
Average response-9.4%9 measured reactions
Result-price confirmation44%same directional sign
Surprise variability70.8 ptspopulation dispersion

Estimate delivery

Actual EPS versus consensus

Actual and estimated EPS are displayed in reported currency on the same quarterly basis.

Price acceptance

Surprise and next weekly close

The response uses the first completed weekly close after the public report against the prior completed weekly close.

Fundamental delivery

Quarterly revenue and net income

Reported financial statements provide scale and earnings quality context around the headline EPS result.

Transmission matrix

Does price confirm delivery?

Upper right and lower left observations confirm the sign of delivery. The other quadrants expose expectation or resilience effects.

Current business context

Growth, quality and valuation

As of 9 Aug 2026
EPS growth-year on year
Revenue growth-year on year
Average surprise-6.6%latest four quarters
SUE-0.27standardised surprise
Net margin-23.8%trailing basis
Cash conversion-0.61xcash flow / net income
P/E-current snapshot
Data completeness71%alphavantage

Market context

Positioning into the event

Week ending 7 Aug 2026
Weekly close5.01 USDcompleted week
13-week return4.6%price momentum
Fair-value gap-23.0%price versus current fair value
Relative strength-32.4exchange benchmark
Trend signalInactiveweekly architecture
Next-week stateUndecided47.6%

Market context describes the setup surrounding the report. It does not convert the earnings event into a directional forecast.

Reported evidence ledger

Quarter-by-quarter delivery and acceptance

Each row preserves the reported estimate, public date, statement context and conservative weekly reaction measurement.

12 quarters
Reported / periodEPS actual / estimateSurpriseEPS growthRevenue / growthNext close / four weeksRead
Reported / perioddate unavailable30 Jun 2026 · period only
EPS actual / estimate-0.19 / -0.22USD
Surprise+0.1%In-Line
EPS growth-90.0%year on year
Revenue / growth34167000-6.2% · USD
Next close / four weeks- / -completed weekly closes
ReadUnavailableresult versus price sign
Reported / period5 Aug 202631 May 2026 · exact
EPS actual / estimate-0.19 / -0.17USD
Surprise-11.8%Miss
EPS growth-90.0%year on year
Revenue / growth34167000-6.2% · USD
Next close / four weeks+13.3% / -completed weekly closes
ReadDivergedresult versus price sign
Reported / perioddate unavailable31 Mar 2026 · period only
EPS actual / estimate-0.43 / -0.30USD
Surprise-0.4%In-Line
EPS growth+8.5%year on year
Revenue / growth23193000-34.0% · USD
Next close / four weeks- / -completed weekly closes
ReadUnavailableresult versus price sign
Reported / period16 Mar 202628 Feb 2026 · exact
EPS actual / estimate-0.16 / -0.23USD
Surprise+30.4%Beat
EPS growth+66.0%year on year
Revenue / growth30750592-12.5% · USD
Next close / four weeks-38.5% / -27.4%completed weekly closes
ReadDivergedresult versus price sign
Reported / perioddate unavailable31 Dec 2025 · period only
EPS actual / estimate-0.16 / -0.16USD
Surprise0.0%In-Line
EPS growth+20.0%year on year
Revenue / growth-- · USD
Next close / four weeks- / -completed weekly closes
ReadUnavailableresult versus price sign
Reported / period1 Jan 202630 Nov 2025 · exact
EPS actual / estimate0.00 / -0.16USD
Surprise+100.0%Beat
EPS growth+100.0%year on year
Revenue / growth-- · USD
Next close / four weeks-6.7% / +3.4%completed weekly closes
ReadDivergedresult versus price sign
Reported / period6 Nov 202531 Aug 2025 · exact
EPS actual / estimate-0.43 / -0.30USD
Surprise-43.3%Miss
EPS growth-16.2%year on year
Revenue / growth31109000+25.9% · USD
Next close / four weeks-4.7% / +9.9%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period7 Aug 202531 May 2025 · exact
EPS actual / estimate-0.10 / -0.09USD
Surprise-11.1%Miss
EPS growth+41.2%year on year
Revenue / growth36444000-3.8% · USD
Next close / four weeks+3.6% / +8.9%completed weekly closes
ReadDivergedresult versus price sign
Reported / period3 Apr 202528 Feb 2025 · exact
EPS actual / estimate-0.47 / -0.15USD
Surprise-213.3%Miss
EPS growth-year on year
Revenue / growth35154000- · USD
Next close / four weeks-22.8% / -6.9%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period2 Jan 202530 Nov 2024 · exact
EPS actual / estimate-0.20 / -0.30USD
Surprise+33.3%Beat
EPS growth-year on year
Revenue / growth32564000- · USD
Next close / four weeks+4.7% / -13.2%completed weekly closes
ReadConfirmedresult versus price sign
Reported / period4 Oct 202431 Aug 2024 · exact
EPS actual / estimate-0.37 / -0.46USD
Surprise+19.6%Beat
EPS growth-year on year
Revenue / growth24705000- · USD
Next close / four weeks-6.7% / +11.0%completed weekly closes
ReadDivergedresult versus price sign
Reported / period26 Aug 202431 May 2024 · exact
EPS actual / estimate-0.17 / -0.12USD
Surprise-41.7%Miss
EPS growth-year on year
Revenue / growth37886000- · USD
Next close / four weeks-27.0% / -16.7%completed weekly closes
ReadConfirmedresult versus price sign

Reproducible method

How the earnings dossier is measured

Descriptive, not predictive
Estimate delivery

Reported diluted EPS is compared with the stored estimate for the same fiscal period. Moves within ±0.5% are classified as in-line.

Price response

The first completed weekly close after the public date is compared with the prior completed weekly close. Four-week response uses the first close at least 21 days later.

Event risk

Risk combines proximity, average absolute price movement, surprise variability, estimate availability and timing certainty. It does not score direction.

Data discipline

Exact public dates are used when stored. Missing estimates, timing and statement fields remain missing. No result or reaction is filled from a future observation.

Independent market research for education. Not investment advice, a recommendation, forecast, target or execution instruction.

Evidence context